IL17A and cancer: For instance, n-3 PUFAs have been shown to suppress levels of IL-6 and TNF-α in cancer patients (190), as well as reduce IL-17A-mediated inflammation (191) and IL-11 expression in hepatocytes during acetaminophen-induced hepatotoxicity (192).